Episode 35. Bispecific Antibodies in Lymphoma with Dr. Michael Dickinson
Blood Cancer Talks
00:00
Biospecific Antibodies in Treating Refractory Lymphoma
This chapter discusses the potential of biospecific antibodies in treating lymphoma patients who have not responded to CAR T cell therapy. The speakers highlight the advantages and challenges of using biospecific antibodies, comparing response rates and durability of complete remission with CAR T cell therapy. They also discuss the need for larger trials and long-term follow-up to gather more data on the efficacy of biospecific antibodies.
Transcript
Play full episode
